Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000198467 | SCV000249797 | uncertain significance | not provided | 2024-06-18 | criteria provided, single submitter | clinical testing | Identified in a patient with classic Ehlers-Danlos syndrome (cEDS) who also harbored a variant in the COL6A3 gene (PMID: 35723357); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Occurs in the triple helical domain at the Y position in the canonical Gly-X-Y repeat; although this variant may have an effect on normal protein folding and function, missense substitution at the Y position is not a common mechanism of disease (PMID: 22696272, HGMD); This variant is associated with the following publications: (PMID: 35723357, 22696272) |
Labcorp Genetics |
RCV002229041 | SCV000548972 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2024-12-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002399719 | SCV002712492 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2024-02-24 | criteria provided, single submitter | clinical testing | The p.P576S variant (also known as c.1726C>T), located in coding exon 15 of the COL5A1 gene, results from a C to T substitution at nucleotide position 1726. The proline at codon 576 is replaced by serine, an amino acid with similar properties. This variant was reported in an individual with classic Ehlers-Danlos syndrome (Junkiert-Czarnecka A et al. Curr Issues Mol Biol. 2022 Mar;44(4):1472-1478). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV000198467 | SCV004225169 | uncertain significance | not provided | 2023-06-22 | criteria provided, single submitter | clinical testing | BS1 |